Immunosuppression and reactivation of hepatitis B in the lamivudine era: Opportunities for prevention and exploitation?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 8, 1999, Pages 741-744

  Farrell, G C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON; LAMIVUDINE; VIRUS DNA;

DRUG EFFICACY; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0032883368     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01962.x     Document Type: Editorial

References (25)